维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="ESEUDIER B"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	A 10 -year clinical experience with intermittent hormonal therapy for pros- tate cancer显示文摘	PRAPOTNICH D FIZAZI K ESEUDIER B	2003	Eur Urol2003，43，3：	1
2	Bevaeizumab plus interferon alfa-2a for treatment of metastatic renal cell eareinoma~ a randomized, double-blind phase Ⅲ trial 显示文摘	Eseudier B Pluzanska A Koralewski P	2007	Lancet2007，370，9605：	1
3	Phase 3 trial of everoli- mus for metastatic renal cell carcinoma: final results and analysis of prognostic factors 显示文摘	Motzer R J Eseudier B Oudard S	2010	Cancer2010，116，18：	1
4	Sorafenib in advanced clear - cell renal - cell carcinoma 显示文摘	Eseudier B Eisen T Stadler WM	2007	New England Journal of Medicine2007，356，2：	1
5	Bevaeizumab pIus in- terferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase Ⅲ trial 显示文摘	Eseudier B Koralewski P Pluzanska A	2007	Lancet2007，370，：	1
6	Sorafenib in advanced clear-cell renal-eell eareinoma显示文摘	Eseudier B Eisen T Stadler WM	2007	N Engl J Med2007，356，2：	1
7	Update On the different histological types of renal cell carcinoma and their specific显示文摘	Neuzillet Y Rioux-Ledereq N Eseudier B		0，，01：	1
8	Asymptotic wavelet and gabor analysis: extraction of instantaneous fre- quencies 显示文摘	Delprat N Eseudie B Guillemain P	1992	IEEE Transactions on Information Theory1992，38，2：	1
9	Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors 显示文摘	Motzer R J Eseudier B Oudard S	2010	Cancer2010，116，18：	1
10	Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trail显示文摘	Eseudier B Chaput N	2005	Transl Med2005，3，1：	1
11	Renal cell carcinoma显示文摘	RINN BI CAMPBELL SC ESEUDIER B	2009	Lancet2009，373，9669：	1
12	Axitinib versus sorafenib as second - line treatment for advanced renal cell carcinoma: O- verall survival analysis and updated results from a randomised phase 3 trial显示文摘	Motzer RJ Eseudier B Tomezak P	2013	Lancet Onco12013，14，6：	1
13	Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors 显示文摘	Motzer R J Eseudier B J Oudard S	2010	Cancer2010，116，18：	1
14	Renal cell carcinoma显示文摘	Rini BI Campbell SC Eseudier B	2009	Lan- cet2009，373，9669：	1
15	Bevacizum- ab plus interferon alfa-2a for treatment of' metastatic renal cell carcinoma: a randomised,double-blind phase m trial显示文摘	Eseudier B Pluzanska A Koralewski P	2007	Lancet2007，370，9605：	1
16	Sorafenib in advanced clear-cell renal-cell carcinoma显示文摘	Eseudier B Eisen T Stadler W M	2007	N Engl J Med2007，356，2：	1
17	Renal cell carcinoma显示文摘	Rinn BI Campbell SC Eseudier B	2009	Lancet2009，373，9669：	1
18	Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma:a randomized,double-blind phase Ⅲ trial显示文摘	Eseudier B Pluzanska A Koralewski P	2007	Lancet2007，370，9605：	1
19	Treatment selection in meta- static renal cell carcinoma:expert consensus 显示文摘	Eseudier B Szezylik C Porta C	2012	Nat Rev Clin On- col2012，9，6：	1
20	Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘	Rini BI Eseudier B Tomezak P	2011	Lancet2011，378，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示